Carlyle Pays Almost $500m For A Fifth Of Piramal Pharma

Carlyle's 20% Stake Gives Piramal Pharma 'War Chest' For Growth

 
• By Anju Ghangurde
  
Acquisition
Carlyle Bets On Piramal Pharma • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business